Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Functionally Validated Structural Endpoints for Early AMD

Authors not listed

Cynthia Owsley · 2019

Abstract

Delayed rod-mediated dark adaptation (RMDA), or delayed recovery of vision in a dark environment, is a functional biomarker (i.e., risk factor) for early age-related macular degeneration (AMD). This research plan is designed to elucidate the structural (anatomical) basis of this visual deficit using cellular- and subcellular level imaging of the retina and its supporting tissues in living people. An accurate map and timeline of structure-function relationships in persons tested for night vision will result in functionally validated structural endpoints for early AMD trials, as well as define major biologic effects for development into future treatments.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-05-31 MST

Cite this

APA
Anonymous. (2019). Functionally Validated Structural Endpoints for Early AMD. <em>Cynthia Owsley</em>. https://clinicaltrials.gov/study/NCT04112667
Vancouver
Anonymous. Functionally Validated Structural Endpoints for Early AMD. Cynthia Owsley. 2019.
BibTeX
@misc{anon2019Functi, title = {Functionally Validated Structural Endpoints for Early AMD}, author = {Anonymous}, journal = {Cynthia Owsley}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings